CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $6,593,000 | +173.3% | 420,500 | +83.8% | 0.33% | +135.7% |
Q3 2015 | $2,412,000 | -66.9% | 228,800 | -20.7% | 0.14% | -64.5% |
Q2 2015 | $7,281,000 | -9.5% | 288,700 | 0.0% | 0.39% | -34.9% |
Q1 2015 | $8,046,000 | +52.7% | 288,700 | 0.0% | 0.60% | +5.2% |
Q4 2014 | $5,269,000 | +40.8% | 288,700 | 0.0% | 0.58% | +10.2% |
Q3 2014 | $3,742,000 | -20.6% | 288,700 | 0.0% | 0.52% | -18.6% |
Q2 2014 | $4,712,000 | -7.6% | 288,700 | 0.0% | 0.64% | -19.1% |
Q1 2014 | $5,101,000 | -18.0% | 288,700 | +12.3% | 0.79% | -58.7% |
Q4 2013 | $6,222,000 | – | 257,000 | – | 1.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,000 | $1,359,000 | 100.00% |
TSP Capital Management Group, LLC | 236,919 | $1,197,000 | 0.67% |
Meditor Group Ltd | 6,312,700 | $1,249,000 | 0.26% |
Anson Funds Management LP | 1,229,844 | $243,000 | 0.14% |
Cresset Asset Management, LLC | 6,865,000 | $1,359,000 | 0.08% |
Telemetry Investments, L.L.C. | 348,501 | $69,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 789,260 | $156,000 | 0.02% |
Benchmark Capital Advisors | 32,600 | $6,000 | 0.01% |
BOENNING & SCATTERGOOD, INC. | 74,950 | $15,000 | 0.01% |
Stratos Wealth Partners, LTD. | 250,000 | $49,000 | 0.00% |